Table 3 Results of multivariate logistic regression analysis of variables associated with recurrent PJI

1^st Albumin

0.11 (0.04—3.81)

0.342

2^nd Albumin

0.13 (0.02—3.21)

0.231

3-stage revision arthroplasty or more

35.02 (1.4—50.63)

 < 0.001^*

E. Coli

3.67 (0.19—10.31)

0.22

ESBL-E. Coli

12.33 (1.16—15.55)

 < 0.001^*

Fasting glucose, mmol/l

  100 to <  = 200

1.58 (0.19—8.54)

1

  > 200

2.16 (0.22—9.85)

0.64

  1^st HbA1c ≥ 7

3.67 (0.21—3.21)

0.32

Last stage HbA1c ≥ 7

28.34 (1.2—40.12)

 < 0.001^*

Sulfonylurea (Glipizide, Glimepiride, Gliclazide)

3.21 (0.25—11.24)

0.34

DPP4 inhibitor (Saxagliptin, Linagliptin, Alogliptin, Vildagliptin)

2.58 (0.19—9.32)

0.32

Insulin combined with other OAD Insulin

5.18 (0.28—13.36)

0.12

ACE inhibitor or ARB

0.64 (0.09—8.95)

1